These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8047829)

  • 21. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
    Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
    Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
    Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
    Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
    Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
    Hassall E; Shepherd R; Koletzko S; Radke M; Henderson C; Lundborg P
    Aliment Pharmacol Ther; 2012 Feb; 35(3):368-79. PubMed ID: 22176465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.
    Lind T; Havelund T; Lundell L; Glise H; Lauritsen K; Pedersen SA; Anker-Hansen O; Stubberöd A; Eriksson G; Carlsson R; Junghard O
    Aliment Pharmacol Ther; 1999 Jul; 13(7):907-14. PubMed ID: 10383525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.
    Robinson M; Fitzgerald S; Hegedus R; Murthy A; Jokubaitis L;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):445-54. PubMed ID: 11876697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice.
    Venables TL; Newland RD; Patel AC; Hole J; Copeman MB; Turbitt ML
    Scand J Gastroenterol; 1997 Jul; 32(7):627-32. PubMed ID: 9246699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group.
    Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Thor K; Lamm M; Blomqvist A; Hatlebakk JG; Janatuinen E; Levander K; Nyström P; Wiklund I
    Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):879-87. PubMed ID: 10958215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
    Stålhammar NO; Carlsson J; Peacock R; Müller-Lissner S; Bigard MA; Porro GB; Ponce J; Hosie J; Scott M; Weir DG; Fulton C; Gillon K; Bardhan KD
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 1):483-97. PubMed ID: 10662395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
    Zeitoun P
    Scand J Gastroenterol Suppl; 1989; 166():83-7; discussion 94. PubMed ID: 2690335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
    Barradell LB; McTavish D
    Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: management of mild and severe gastro-oesophageal reflux disease.
    Tytgat GN
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():52-6. PubMed ID: 12786613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN; Orlando R; Joelsson B
    Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.